CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 52 target
Drug / intervention
Imaging guidance with TEE and ICE for Left atrial appendage closuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06061757
NCT06061757N/ARecruitingUpdate OverdueUpdated 10mo ago · Completion was 6mo ago
Enrollment Stalled
Long Recruiting
Update Overdue

Use of 4D Intracardiac Echocardiography (4D-ICE) in Conjunction With Transesophageal Echocardiography (TEE) for Left Atrial Appendage Closure (LAAC)

Kansas City Heart Rhythm Research Foundation·interventional·Posted Sep 29, 2023·Updated Aug 28, 2025

In Brief

A clinical study evaluating Imaging guidance with TEE and ICE for Left atrial appendage closure for Atrial Fibrillation and Stroke. Currently recruiting, targeting 52 participants across 1 site.

Signals

Enrollment appears stalled

Detailed Summary

This is a prospective, single center, non-randomized study with two parallel arms intended to study if 4D Intracardiac echocardiography (4D-ICE) (Nuvision, Nuvera TM) will provide better visualization of the anatomical landmarks from the larger imaging volume and provide optimal intra procedural guidance similar to Transesophageal echocardiography (TEE) (GE 6VT-D ULTRASOUND TRANSDUCER) for Left atrial appendage closure (LAAC). The study will enroll approximately 52 subjects and will be followed through 12 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ARecruitingOverdue
202420252026
First PostedSep 29, 2023
Enrollment StartMay 10, 2023
Primary CompletionDec 31, 2025
TodayJul 1, 2026
Enrollment to primary: 2.6 yearsPosted 2.8 years ago

Interventions

Imaging guidance with TEE and ICE for Left atrial appendage closuredevice

The occluder size for both LAAC devices will be selected based on the maximal diameter of the LAA orifice following the manufacturer guidelines and using the maximal length of the LAA measured on Echocardiogram. Intraprocedural measurements of the LAA width and depth were acquired on both ICE and TEE per protocol. Both ICE and TEE will be used to assess for any procedural complications prior to insertion of the device delivery sheath.